Inovio Pharmaceuticals (INO) Market Capitalization (2010 - 2026)

Inovio Pharmaceuticals has disclosed Market Capitalization across 17 years of filings, most recently posting $89.8 million for Q2 2026.

• In Q2 2026, Market Capitalization rose 13.62% year-over-year to $89.8 million; the TTM figure through Jun 2026 stood at $89.8 million (up 13.62% YoY), while the FY2025 annual figure was $81.6 million, up 64.14% from the prior year.
• Market Capitalization came in at $89.8 million for Q2 2026 at Inovio Pharmaceuticals, down from $143.2 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $822.2 million in Q1 2022 to a low of $49.7 million in Q4 2024.
• Average Market Capitalization over 5 years is $222.7 million, with a median of $141.3 million recorded in 2023.
• Year-over-year, Market Capitalization slumped 83.38% in 2025 and surged 139.47% in 2026.
• Over 5 years, Market Capitalization stood at $394.8 million in 2022, then slumped by 64.67% to $139.5 million in 2023, then sank by 64.37% to $49.7 million in 2024, then surged by 64.14% to $81.6 million in 2025, then grew by 10.05% to $89.8 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $89.8 million in Q2 2026, $143.2 million in Q1 2026, and $81.6 million in Q4 2025.